Rs 11 IV set, Rs 325 MRP: Maharashtra FDA asks Centre to bring essential devices under price control
Maharashtra's food and drug administration noted significant price differences for hospital medical devices. Procurement costs were substantially lower than declared maximum retail prices for many items. The agency has requested central government intervention to examine these pricing discrepancies. Essential medical devices used during inpatient treatment require greater transparency and oversight. This situation highlights regulatory gaps and potential increases in patient healthcare expenditure. Maharashtra’s food and drug administration noted significant price differences for hospital medical devices. Procurement costs were substantially lower than declared maximum retail prices for many items. The agency has requested central government intervention to examine these pricing discrepancies. Essential medical devices used during inpatient treatment require greater transparency and oversight. This situation highlights regulatory gaps and potential increases in patient healthcare expenditure.
About the Author
